|
Volumn 23, Issue 5, 2002, Pages 225-231
|
Functional versus chemical diversity: Is biodiversity important for drug discovery?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
ARTEMISIN;
ATROPINE;
AVERMECTIN;
BMS 192548;
CAMPTOPHTHECIN;
CHEMICAL COMPOUND;
DICOUMAROL;
DIGOXIN;
DNA TOPOISOMERASE INHIBITOR;
EPHEDRINE;
ERGOCORNINE;
FUSIDIC ACID;
GENTAMICIN;
GRISEOFULVIN;
GW 311616A;
HARMALINE;
HEPARIN;
LIGAND;
MEVINOLIN;
MORPHINE;
NEW DRUG;
PACLITAXEL;
PAPAVERINE;
PENICILLIN G;
PHYSOSTIGMINE;
PODOPHYLLOTOXIN;
QUINIDINE;
RAPAMYCIN;
SALICYLIC ACID;
SCH 202596;
TRABECTEDIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WIN 64821;
BIODIVERSITY;
DRUG ACTIVITY;
DRUG MECHANISM;
DRUG STRUCTURE;
ECOSYSTEM;
GENE SEQUENCE;
HUMAN;
MOLECULAR MECHANICS;
MOLECULE;
NATURAL SCIENCE;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
SPECIES DIFFERENCE;
TROPICAL RAIN FOREST;
ANIMALS;
DRUG DESIGN;
HUMANS;
MORPHINE;
NICOTINE;
PACLITAXEL;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0036570328
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(02)02007-2 Document Type: Review |
Times cited : (72)
|
References (33)
|